Wockhardt, Jemincare partner for novel respiratory antibiotic Nafithromycin

On the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-Microbial Resistance (AMR) which has been identified as one of the top threats by WHO.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38cAp0b
via IFTTT

0 comments:

Post a Comment